Ionis Pharmaceuticals, Inc.
(NASDAQ : ISIS)

( )
ISIS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.83%191.561.2%$567.63m
GILDGilead Sciences, Inc.
-0.97%70.490.9%$501.34m
BIIBBiogen Inc.
-1.94%318.901.3%$457.42m
CELGCelgene Corporation
-4.05%71.021.2%$422.10m
ILMNIllumina, Inc.
-5.73%310.393.5%$402.00m
REGNRegeneron Pharmaceuticals, Inc.
-2.83%346.562.6%$291.08m
VRTXVertex Pharmaceuticals Incorporated
-4.27%172.851.9%$281.35m
ALXNAlexion Pharmaceuticals, Inc.
-3.92%118.602.0%$203.65m
AAgilent Technologies, Inc.
-4.12%64.501.5%$169.81m
LGNDLigand Pharmaceuticals Incorporated
-1.97%155.4723.3%$152.44m
EXASExact Sciences Corporation
-8.54%68.2525.3%$149.11m
SRPTSarepta Therapeutics, Inc.
-3.70%120.8216.4%$136.29m
ECYTEndocyte, Inc.
-0.04%23.552.0%$123.58m
INCYIncyte Corporation
-4.80%62.862.5%$111.57m
BMRNBioMarin Pharmaceutical Inc.
-2.72%93.074.3%$110.69m

Company Profile

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.